BR0015170A - Proteìnas de hcv com oxirredução reversìvel e conformação similar à nativa - Google Patents
Proteìnas de hcv com oxirredução reversìvel e conformação similar à nativaInfo
- Publication number
- BR0015170A BR0015170A BR0015170-0A BR0015170A BR0015170A BR 0015170 A BR0015170 A BR 0015170A BR 0015170 A BR0015170 A BR 0015170A BR 0015170 A BR0015170 A BR 0015170A
- Authority
- BR
- Brazil
- Prior art keywords
- hcv proteins
- native
- conformation similar
- reversible redox
- relates
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 5
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 230000002441 reversible effect Effects 0.000 title abstract 2
- 235000018102 proteins Nutrition 0.000 abstract 4
- 238000000746 purification Methods 0.000 abstract 2
- 230000004071 biological effect Effects 0.000 abstract 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000007877 drug screening Methods 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
- C07K16/109—Hepatitis C virus; Hepatitis G virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99870225 | 1999-10-27 | ||
| US16928899P | 1999-12-07 | 1999-12-07 | |
| PCT/EP2000/010499 WO2001030815A1 (en) | 1999-10-27 | 2000-10-25 | Redox reversible hcv proteins with native-like conformation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0015170A true BR0015170A (pt) | 2002-06-25 |
Family
ID=30129297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0015170-0A BR0015170A (pt) | 1999-10-27 | 2000-10-25 | Proteìnas de hcv com oxirredução reversìvel e conformação similar à nativa |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1224214A1 (zh) |
| JP (1) | JP2003513022A (zh) |
| CN (1) | CN1384839A (zh) |
| AU (1) | AU1144501A (zh) |
| BR (1) | BR0015170A (zh) |
| CA (1) | CA2387666A1 (zh) |
| CZ (1) | CZ20021819A3 (zh) |
| HU (1) | HUP0203195A3 (zh) |
| MX (1) | MXPA02004052A (zh) |
| NZ (1) | NZ518095A (zh) |
| PL (1) | PL354990A1 (zh) |
| RU (1) | RU2002109480A (zh) |
| WO (1) | WO2001030815A1 (zh) |
| ZA (1) | ZA200203169B (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001273348A1 (en) * | 2000-07-10 | 2002-01-21 | Diosynth Rtp, Inc. | Purification of human troponin i |
| NZ529324A (en) * | 2001-04-24 | 2005-08-26 | Innogenetics N | Core-glycosylated HCV envelope proteins made in yeast cells |
| EP1481984A1 (en) * | 2003-05-28 | 2004-12-01 | Innogenetics N.V. | Modified hepatitis C virus (HCV) NS5 |
| CN105209616A (zh) * | 2013-03-14 | 2015-12-30 | 雅培制药有限公司 | 用于改进的抗体检测的hcv ns3重组抗原及其突变体 |
| EP3756648A1 (en) * | 2019-06-27 | 2020-12-30 | Imnate Sarl | Improved vaccine formulations |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4734362A (en) * | 1986-02-03 | 1988-03-29 | Cambridge Bioscience Corporation | Process for purifying recombinant proteins, and products thereof |
| AU652919B2 (en) * | 1989-06-02 | 1994-09-15 | Genetic Systems Corporation | Cysteine thiol-protected peptides for use in immunoassays |
| BR9506059A (pt) * | 1994-07-29 | 1997-10-28 | Innogenetics Nv | Proteinas envelopes purificadas de virus c para uso de diagnóstico e terapêutico |
| GB9703406D0 (en) * | 1997-02-19 | 1997-04-09 | Chiron Spa | Expression of heterologous proteins |
| EP0947525A1 (en) * | 1998-03-27 | 1999-10-06 | Innogenetics N.V. | Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue |
-
2000
- 2000-10-25 BR BR0015170-0A patent/BR0015170A/pt not_active IP Right Cessation
- 2000-10-25 NZ NZ518095A patent/NZ518095A/en unknown
- 2000-10-25 EP EP00972863A patent/EP1224214A1/en not_active Withdrawn
- 2000-10-25 AU AU11445/01A patent/AU1144501A/en not_active Abandoned
- 2000-10-25 WO PCT/EP2000/010499 patent/WO2001030815A1/en active Search and Examination
- 2000-10-25 MX MXPA02004052A patent/MXPA02004052A/es unknown
- 2000-10-25 HU HU0203195A patent/HUP0203195A3/hu unknown
- 2000-10-25 CN CN00814993A patent/CN1384839A/zh active Pending
- 2000-10-25 RU RU2002109480/13A patent/RU2002109480A/ru not_active Application Discontinuation
- 2000-10-25 PL PL00354990A patent/PL354990A1/xx not_active Application Discontinuation
- 2000-10-25 CZ CZ20021819A patent/CZ20021819A3/cs unknown
- 2000-10-25 CA CA002387666A patent/CA2387666A1/en not_active Abandoned
- 2000-10-25 JP JP2001533812A patent/JP2003513022A/ja active Pending
-
2002
- 2002-04-22 ZA ZA200203169A patent/ZA200203169B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0203195A3 (en) | 2004-07-28 |
| AU1144501A (en) | 2001-05-08 |
| ZA200203169B (en) | 2003-09-23 |
| MXPA02004052A (es) | 2002-11-07 |
| JP2003513022A (ja) | 2003-04-08 |
| HUP0203195A2 (hu) | 2002-12-28 |
| WO2001030815A1 (en) | 2001-05-03 |
| EP1224214A1 (en) | 2002-07-24 |
| CZ20021819A3 (cs) | 2003-06-18 |
| CA2387666A1 (en) | 2001-05-03 |
| RU2002109480A (ru) | 2004-03-10 |
| PL354990A1 (en) | 2004-03-22 |
| CN1384839A (zh) | 2002-12-11 |
| NZ518095A (en) | 2003-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Marrero et al. | The crystal structure of human α2‐macroglobulin reveals a unique molecular cage | |
| CY1120558T1 (el) | Ενας rdεν3/4δελτα 30(με),rdεν2/4δελτα30(με) ή rdεν1/4δελτα30(με) ανασυνδυασμενος χιμαιρικος ιος του δαγγειου πυρετου ο οποιος περιεχει μια 30 νουκλεοτιδιων διαγραφη (δελτα30) σε ενα τμημα της 3' αμεταφραστης περιοχης του γονιδιωματος ιου του δαγγειου πυρετου τυπου 4, οπου η εν λογω 30 νουκλεοτιδιων διαγραφη αντιστοιχει στην tl2 δομη στελεχους- βροχου | |
| RU95115239A (ru) | Аналог эритропоэтина | |
| BRPI0507026A (pt) | proteìnas de fusão de albumina | |
| DE69435075D1 (de) | , die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten | |
| ATE252151T1 (de) | Apoptosegen von wirbeltieren, zusammensetzungen und verwendungen | |
| DE60032486D1 (de) | Prion protein peptide und deren verwendung | |
| BR9909860A (pt) | Polipeptìdeos cd19xcd3 especìficos e usos dos mesmos | |
| DE69738581D1 (de) | Menschliche dnase i hyperaktive varianten | |
| BR0211623A (pt) | Agentes de contraste alvos multiméricos com base em peptìdeo | |
| PT1012280E (pt) | Modulo de trimerizacao | |
| DK1005540T3 (da) | IKK-beta-proteiner, nukleinsyrer og fremgangsmåder | |
| BR9814276A (pt) | Antìgenos de superfìcie | |
| BR0112540A (pt) | Peptìdios como inibidores da ns-3-serina protease do vìrus da hepatite c | |
| DK0750672T3 (da) | DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse | |
| TR200003159T2 (tr) | Antipicornaviral bileşikler, hazırlanışları ve kullanımları | |
| DE69130071D1 (de) | Zusammensetzung verwendbar als therapeutisches mittel gegen chronische virale leberkrankheiten | |
| BRPI0407533A (pt) | proteìnas de fusão e muteìnas do interferon alfa com propriedades melhoradas | |
| BR0015170A (pt) | Proteìnas de hcv com oxirredução reversìvel e conformação similar à nativa | |
| ATE177843T1 (de) | Peptomere mit erhöhter immunogenizität | |
| DE50212280D1 (de) | Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren | |
| HUP0003116A2 (hu) | Béta-amiloid-peptid-kötő fehérjék és az őket kódoló polinukleotidok | |
| ATE554793T1 (de) | Konjugat | |
| NO995692D0 (no) | Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse | |
| BR0208109A (pt) | Derivados de guanidina bicìclicos e usos terapêuticos destes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008. |